Fundraising Fox

Abolis

Saudi Arabia, SA · 4 known investors

Abolis is a microbial biotechnology company that designs custom microorganisms to produce ingredients sustainably using metabolic engineering, fermentation, and machine learning. The company serves cosmetics, healthcare, nutrition, and specialty chemicals industries with tailored biosolutions for manufacturing.

Advanced ManufacturingAI & Machine LearningBiotechCircular Economy

Founders & leadership

CPCyrille PAUTHENIER
Cyrille PAUTHENIERinFounder, Owner & CEO

Investors · 4

DeepTech & Climate FondsMunich · $5.5M – $55M

Also in the syndicate · 3

EvonikGenopoleL'Oreal

In the news

Abolis raises €35 million from an international consortium - Genopole, Innovation Today, Every Daygenopole.com · Sep 2024Abolis Biotechnologies Raises €35M in Fundingfinsmes.com · Sep 2024L'Oreal, Evonik join $38.6 mln funding round for biotech start-up Abolis | Reutersreuters.com · Sep 202435 million euro for sustainable biotech: International consortium invests into Abolis Biotechnologiesevonik.com · Sep 2024French biotech Abolis Biotechnologies raises €35M to boost microbial ecosystem engineering - Tech.eutech.eu · Sep 2024Abolis Biotechnologies Secures 35 Mio. Euro From International Consortium of Industrials and Fundsbusinesswire.com · Sep 2024

Frequently asked questions

What does Abolis do?
Abolis is a microbial biotechnology company that designs custom microorganisms to produce ingredients sustainably using metabolic engineering, fermentation, and machine learning. The company serves cosmetics, healthcare, nutrition, and specialty chemicals industries with tailored biosolutions for manufacturing.
Who founded Abolis?
Abolis was founded by Cyrille PAUTHENIER.
Who are Abolis's investors?
Abolis's investors include DeepTech & Climate Fonds.
Where is Abolis headquartered?
Abolis is headquartered in Saudi Arabia, SA.